practical considerations for introducing biosimilars
Published 4 years ago • 2 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
4:53
the value and strategy for incorporating biosimilars into clinical practice
-
7:46
practical considerations in integrating her2 biosimilars in clinical practice
-
2:47
biosimilars: approval process
-
4:36
the extrapolation of biosimilar indications: understand the practical implications
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
3:17
practical guidance on the assessment of biosimilar monoclonal antibodies: a pharmacist's perspec...
-
4:40
practical guidance on the assessment of biosimilar monoclonal antibodies: a physician's perspective
-
3:33
biosimilars: manufacturing and inherent variation
-
19:32
assessment of complex drug product – physicochemical characteristics to support in vitro be studies
-
7:21
biologic drugs and biosimilars
-
1:02:10
introduction of biosimilars on the nhs
-
21:22
the introduction of biosimilar drugs to the nhs with prof. richard gale
-
1:36
interchangeable biosimilars
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
1:28
the role of pharmacists when introducing biosimilar monoclonal antibodies into practice
-
5:07
biosimilar interchangeability in practice
-
1:15:43
biosimilars: full event
-
1:16
practical intricacies surrounding biosimilar adoption
-
0:57
what's the difference between a biologic and a biosimilar?
-
3:42:11
pharmacodynamic biomarkers for biosimilar development and approval: day 2
-
6:00
quick guide to biosimilars